More on CELG

- Summary
- Chart
- Profile
- Historical


- Earnings (+20.3% Growth)
- Ratings (7.6 Score)
- Holders
- Event Driven Deals


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/27/16)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

CELG Income Statement

Click line-items for a historical chart and %
Net product sales 2.74B
Collaborative agreements and other revenue 9.8M
Royalty revenue
Total revenue 2.75B
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 948.7M
Selling, general and administrative 732.1M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net -35.9M
Total costs and expenses 1.93B
Operating income 823.7M
Other income and expense:
Interest and investment income, net 7.2M
Equity in (gains) losses of affiliated companies
Interest expense -123.3M
Other income, net -12.5M
Income before income taxes 695.1M
Income tax provision 96.9M
Net income 598.2M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.77
Diluted 0.75
Weighted average shares:
Basic 775.6M
Diluted 801.5M